Profit growth and organic development lagged expectations due to sector-specific challenges and acquisition delays. EBITDA rose 11% and sales 6% year-to-date, with improved margins and stable leverage. Acquisition competition and valuation remain key hurdles.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.